Stay tuned and follow the latest developments and news in Molecular Oncology.
11 July, 2023
Report of a germline double heterozygote in MSH2 and PALB2
Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe,Stavroula Kampouri, Eleni Patsea, George Lypas
Manage Consent
In order to provide the best possible experience, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as your browsing behavior or unique identifiers on this website. If you do not give or withdraw consent, some functions and features of the website may be adversely affected.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
